Press releaseGlobe Newswire
Immix Biopharma
IMMX · NASDAQ
$8.91+$0.69 (+8.39%)TodayMarket closed ·
Prev close $8.22
Latest news
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
- Press releaseBusiness Wire
IMMX Investors Have Opportunity to Join Immix Biopharma, Inc. Fraud Investigation with SBS Law
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
- Press releaseGlobe Newswire
IMMX INVESTOR ALERT: Holzer & Holzer, LLC Announces Investigation of Immix Biopharma, Inc.
- Press releaseGlobe Newswire
IMMX ALERT: Immix Biopharma Investigated for Securities Fraud Violations by Block & Leviton; Investors Should Contact the Firm
- News
Watching Immix Biopharma; Shares Trading Lower, Traders Circulate STAT News Article Titled 'A Most-Wanted Fugitive Appears To Have Been Secretly Working As A Biotech Executive'
- NewsVandana Singh
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions
- NewsVandana Singh
What's Going On With Immix Biopharma Stock Thursday?
- Press releaseGlobe Newswire
At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
Immix Biopharma Attends FDA CEO Forum in Washington DC
- News
Market-Moving News for May 23rd
- NewsAvi Kapoor
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.